FDA Outlines Path For Guidance On Clinical Decision Support Tools
This article was originally published in The Gray Sheet
Executive Summary
CDRH officials are looking for ways to better define when and how clinical decision support tools included in mobile health applications or medical software should face FDA regulation.
You may also be interested in...
Classifying Health IT Still Key Focus For Digital Health Regulation
Conceptual fuzziness still an issue with regulating health IT, observers agree.
Device Tax Threatens Mobile App Developers; For Now, Though, Uncertainty Reigns
Questions about how the medical device tax could impact software application developers emerged at a June 20 American Enterprise Institute workshop.
IBM Watson Exec Eyes Oncology Advisors Pilot
Dan Cerutti, general manager of IBM Watson commercialization, offered a status update June 5 on a health care application for the computer technology.